Polyrizon Ltd. (NASDAQ: PLRZ) Files 2025 Annual Report with SEC
Key Developments Polyrizon Ltd. (NASDAQ: PLRZ), an innovative biotech company specializing in intranasal protective treatments, has officially submitted its Annual Report on Form 20-F for the fiscal year ending December 31, 2025. The filing was made with the U.S. Securities and Exchange Commission, marking a regulatory compliance milestone for the company. This filing encompasses a detailed overview of Polyrizon Ltd.’s progress in the pre-clinical development stages and financial performance throughout…
